Evaluation of Gastrointestinal Transit Pre and Pos Treatment With Non Selective Betablocker in a Population of Cirrhotics

• Status: Unknown status
• Trial end date: 2021-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the influence of non betablockers in gastrointestinal motility (transit time) in patients with liver cirrhosis.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: ALDO TORRE DELGADILLO
• Treatments: Adrenergic beta-Antagonists; Propranolol

Criteria

Inclusion Criteria:

• Cirrhosis of any ethiology

• Child Pugh A, B, C without beta-blocker treatment previously (min. 1 month without treatment)

• Patients with previous variceal bleeding (with liver cirrhosis) * Patients with ascites or bacterial spontaneous peritonitis

Exclusion Criteria:

• Variceal disease without cirrhosis

• Cirrhotics patients that use antibiotics, prebiotics and probiotics during the study period and one month previously

• Patients under immunosuppressor treatment

• Patients with portal thrombosis

• Patients with Sd. Budd-Chiari or cava/suprahepatic thrombosis

• Patients with active infection process